Core Laboratories NV Company Profile (NYSE:CLB)

Analyst Ratings

Consensus Ratings for Core Laboratories NV (NYSE:CLB) (?)
Ratings Breakdown: 3 Sell Rating(s), 9 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Hold (Score: 2.21)
Consensus Price Target: $119.63 (1.64% upside)

Analysts' Ratings History for Core Laboratories NV (NYSE:CLB)
Show:
DateFirmActionRatingPrice TargetActions
7/25/2016Citigroup Inc.Lower Price TargetNeutral$123.00 -> $118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016JPMorgan Chase & Co.DowngradeNeutral -> UnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016ABN AmroDowngradeBuy -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016StephensBoost Price TargetEqual Weight$89.00 -> $98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Morgan StanleyBoost Price TargetOverweight$120.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Howard WeilBoost Price Target$112.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2016ScotiabankReiterated RatingSector Perform$117.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016SunTrust Banks Inc.Lower Price TargetBuy$123.00 -> $109.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016HSBCDowngradeHold -> ReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015GuggenheimUpgradeNeutral -> Buy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2014Evercore ISIInitiated CoverageBuy$151.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014NatixisLower Price Target$170.00 -> $157.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Core Laboratories NV (NYSE:CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/19/2016        
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$1.51$1.53$284.30 million$276.14 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214$1.34$1.35$269.70 million$267.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q114$1.45$1.35$283.02 million$262.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2012$1.10$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2012$1.16$1.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2012$1.07$1.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2012$1.08$1.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/19/2011$0.99$0.93ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2011$0.75$0.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2011$0.81$0.84ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Core Laboratories NV (NYSE:CLB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.35$0.75$0.53
Q2 20163$0.27$0.72$0.45
Q3 20163$0.28$0.77$0.48
Q4 20163$0.32$0.76$0.49
Q1 20172$0.40$0.81$0.61
Q2 20172$0.40$0.88$0.64
Q3 20172$0.43$0.97$0.70
Q4 20172$0.43$1.03$0.73
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Core Laboratories NV (NYSE:CLB)
Annual Dividend:$2.20
Dividend Yield:1.87%
Payout Ratio:117.65% (Based on Trailing 12 Months of Earnings)
135.80% (Based on Current Year Consensus EPS Estimate)
90.16% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:25.20% (3 Year Average)

Dividend History for Core Laboratories NV (NYSE:CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/7/2016Quarterly$0.557/14/20167/18/20168/15/2016Tweet This Announcement  Share This Announcement on StockTwits
4/15/2016Quarterly$0.555/2/20165/4/20165/24/2016Tweet This Announcement  Share This Announcement on StockTwits
1/11/2016Quarterly$0.552.28%1/20/20161/22/20162/19/2016Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015Quarterly$0.5510/21/201510/23/201511/24/2015Tweet This Announcement  Share This Announcement on StockTwits
7/7/2015quarterly$0.552.02%7/15/20157/17/20158/17/2015Tweet This Announcement  Share This Announcement on StockTwits
1/12/2015$0.551/21/20151/23/20152/20/2015Tweet This Announcement  Share This Announcement on StockTwits
10/6/2014quarterly$0.501.39%10/16/201410/17/201411/25/2014Tweet This Announcement  Share This Announcement on StockTwits
7/8/2014quarterly$0.507/16/20147/18/20148/18/2014Tweet This Announcement  Share This Announcement on StockTwits
4/14/2014quarterly$0.501.33%4/23/20144/25/20145/23/2014Tweet This Announcement  Share This Announcement on StockTwits
1/13/2014quarterly$0.501.05%1/22/20141/24/20142/21/2014Tweet This Announcement  Share This Announcement on StockTwits
10/8/2013quarterly$0.320.73%10/16/201310/18/201311/20/2013Tweet This Announcement  Share This Announcement on StockTwits
7/9/2013quarterly$0.320.82%7/17/20137/19/20138/19/2013Tweet This Announcement  Share This Announcement on StockTwits
4/15/2013quarterly$0.321.01%4/24/20134/26/20135/24/2013Tweet This Announcement  Share This Announcement on StockTwits
1/11/2013quarterly$0.321/22/20132/22/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Core Laboratories NV (NYSE:CLB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Core Laboratories NV (NYSE:CLB)
DateHeadline
07/26/16 11:44 AMETF’s with exposure to Core Laboratories NV : July 26, 2016 -
07/24/16 06:00 AMIs This The News Oil Investors Have Been Waiting For? -
07/23/16 07:31 AMEarnings Roundup: Colfax Corporation (NYSE:CFX), Core Laboratories N.V. (NYSE:CLB), Valley National Bancorp ... - Engelwood Daily
07/23/16 07:31 AMShares Stumbling of Late: Core Laboratories NV (NYSE:CLB) - TGP
07/22/16 03:08 PMCORE LABORATORIES N V Files SEC form 10-Q, Quarterly Report -
07/22/16 11:33 AMCore Laboratories NV :CLB-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 -
07/22/16 10:57 AMIs $150 Price Target Attainable For Core Laboratories N.V. (NYSE:CLB)? - Investor Newswire
07/22/16 10:57 AMCore Laboratories NV (CLB) David M. Demshur on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha
07/21/16 08:46 PMCore Laboratories NV (CLB) David M. Demshur on Q2 2016 Results - Earnings Call Transcript
07/21/16 12:43 PMEdited Transcript of CLB earnings conference call or presentation 21-Jul-16 12:30pm GMT -
07/21/16 09:49 AMCore Laboratories (CLB) Q2 Earnings and Revenues in Line -
07/21/16 09:18 AMCore Laboratories N.V. Earnings Bottom Out - The oil-field technology company expects its financial results to start improving.
07/21/16 05:52 AMCore Laboratories N.V. (NYSE:CLB): Analysts Expecting $0.35 Per Share - TGP
07/20/16 10:35 PMCore Laboratories N V : meets 2Q profit forecasts
07/20/16 04:34 PMCore Laboratories meets 2Q profit forecasts -
07/20/16 03:07 PMCORE LABORATORIES N V Files SEC form 8-K, Results of Operations and Financial Condition -
07/20/16 10:55 AMCore Laboratories N.V. (NYSE:CLB): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 10:55 AMArcadia Investment Management Corpmi Lowers stake in Core Laboratories N.V. (CLB) - Trade Calls
07/20/16 06:07 AMQ2 2016 Core Laboratories NV Earnings Release - After Market Close -
07/19/16 07:59 AMOil Stocks to Watch for Earnings on Jul 20: CLB, FTI, HAL -
07/18/16 07:32 AMShould You Buy Core Laboratories (CLB) Ahead of Earnings? -
07/17/16 03:02 PMNext Weeks Broker Price Targets For Core Laboratories N.V. (NYSE:CLB) - Fiscal Standard
07/15/16 07:19 PMCrowd Rating and Earnings Recap for Core Laboratories N.V. (NYSE:CLB) - Telanagana Press
07/15/16 07:19 PMAre Analysts Bearish Core Laboratories N.V. (NYSE:CLB) After Last Week? - Consumer Eagle
07/15/16 07:19 PMCore Laboratories NV Realized Volatility Hits Elevated Level - CML News
07/15/16 07:19 PMStrong Sell Calls For Core Laboratories N.V. (NYSE:CLB) At 0 - Investor Newswire
07/15/16 07:19 PMCore Laboratories N.V. (CLB) Ex-Dividend Date Scheduled for July 14, 2016 - Nasdaq
07/15/16 08:49 AMWill Operating Expenses Hurt Ericsson's (ERIC) Q2 Earnings? -
07/13/16 11:19 AMAnalyst Target and Average Rating Watch: Core Laboratories N.V. (NYSE:CLB) - Press Telegraph
07/13/16 10:30 AMEx-Div Reminder for Core Laboratories (CLB) - Looking at the universe of stocks we cover at Dividend Channel, on 7/15/16, Core Laboratories N.V. (NYSE: CLB) will trade ex-dividend, for its quarterly dividend of $0.55, payable on 8/15/16. As a percentage of CLB's recent stock price of $125.22, this dividend works out to approximately 0.44%. Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen » or click here to find out which 9 other stocks going ex-dividend you should know about, at DividendChannel.com »
07/12/16 08:04 PMThe Word on the Street: Analyst Recommendations for Mid-Cap OFS Stocks -
07/12/16 11:04 AMUnderstanding Mid-Cap OFS Companies’ Correlations with Crude Oil -
07/12/16 11:04 AMA Comparative Valuation of Four Representative OFS Mid-Caps in 2Q16 -
07/11/16 08:02 AMTech innovation is shaking and shaping the Las Vegas machine
07/08/16 03:19 PMIs $150 Within Reach For Core Laboratories N.V. (NYSE:CLB)? - Investor Newswire
07/08/16 02:04 PMInside the Correlation between Core Laboratories’ Stock and Crude Oil -
07/07/16 03:15 PMCore Lab Announces Q3 2016 Quarterly Dividend - [PR Newswire] - AMSTERDAM, July 7, 2016 /PRNewswire/ -- The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US") (Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.55 per share of common stock payable in the third quarter of 2016. This third quarter dividend would mean a total payout of $2.20 per share of common stock if maintained for the entire year. The quarterly $0.55 per share cash dividend will be payable on Monday, 15 August 2016, to shareholders of record on Monday, 18 July 2016. Any determination to declare a future quarterly cash dividend, as well as the amount of any such cash dividend that may be declared, will be based on the Company's financial position, earnings, earnings outlook, capital expenditure plans, ongoing share repurchases, potential acquisition opportunities, and other relevant factors at the time.
07/07/16 03:06 PMCORE LABORATORIES N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
07/05/16 11:46 AMETF’s with exposure to Core Laboratories NV : July 5, 2016 -
07/01/16 03:15 PMEarnest Partners LLC Decreased Stake in Core Labs Nv (NYSE:CLB) by $14.59 Million as Shares Rose - Press Telegraph
06/30/16 08:42 PMCore Laboratories N.V. (NYSE:CLB) Expected to Reach Highs Of $150 - Investor Newswire
06/30/16 08:42 PMCore Laboratories NV (NYSE:CLB) Sellers Covered 7.8% of Their Shorts - Press Telegraph
06/29/16 10:11 AMDid RPC, Inc. Lose Revenue More than OFS Peers in 1Q16? -
06/29/16 10:11 AMInside the One-Year Returns of OFS Peers WFT, CLB, DRQ, and RES -
06/28/16 08:22 PMCovering the Bases on Core Laboratories N.V. (NYSE:CLB): Where is the Stock Going? - Press Telegraph
06/28/16 10:52 AMCore Laboratories NV :CLB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/28/16 10:06 AMWhat Does It Mean that Core Laboratories’ Short Interest Is Declining? -
06/27/16 11:34 AMCore Laboratories' Second Quarter 2016 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On July 21, 2016 - [PR Newswire] - AMSTERDAM, June 27, 2016 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2016 conference call over the Internet ...
06/27/16 10:06 AMUnderstanding Core Laboratories’ Valuation at Its Current Level -
06/27/16 07:50 AMShare Update and Earnings Review for Core Laboratories N.V. (NYSE:CLB) - Press Telegraph

Social

About Core Laboratories NV

Core Laboratories NV logoCore Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company's services and products are directed toward enabling the Company's clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company has over 70 offices in over 50 countries. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from the Company's clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil & Gas Equipment & Services
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: CLB
  • CUSIP:
Key Metrics:
  • Previous Close: $117.70
  • 50 Day Moving Average: $122.75
  • 200 Day Moving Average: $113.97
  • P/E Ratio: 62.44
  • P/E Growth: 3.56
  • Market Cap: $5.12B
  • Beta: 1.47
  • Current Year EPS Consensus Estimate: $1.62 EPS
  • Next Year EPS Consensus Estimate: $2.44 EPS
Additional Links:
Core Laboratories NV (NYSE:CLB) Chart for Tuesday, July, 26, 2016